Plinest® One

  • Suggested for reducing skin laxity and striae distensae in young patients
  • 2 mg/ml PN-HPT® (High Purification Tecnology
  • 5 vials 4ml
  • Available in vials/ampoules

 

Register Account
Categories: ,

Description

Suggested for reducing skin laxity and striae distensae in young patients

Dermal

Serial puncture, linear and cross-hatching technique

2 mg/ml PN-HPT® (High Purification Technology)
5 vials 4ml
Available in vials/ampoules

Phase I: Every 7-14 days for 4 sessions
Phase II: Every 21-30 days for further 4 sessions